Abstract
Cervical cancer is the second leading cause of cancer death in women worldwide. Despite preventive strategies, about 25% of cases are locally advanced at diagnosis, even in developed countries. A decade ago, the standard treatment of locally advanced cervical cancer (CCLA) consists in chemoradiation with platin-based agents and since then, there has been little progress in reducing morbid…